Fundacion De Oftalmologia Medica De La Comunitat Valenciana
- Address
- lock Available on a paid plan
Eye Diseases and Ocular Physiology
At Fundacion De Oftalmologia Medica De La Comunitat Valenciana, much of the research focuses on eye diseases and related ocular physiological phenomena. The trials examine conditions such as dry eye, meibomian gland dysfunction, atopic keratoconjunctivitis, vernal keratoconjunctivitis, persistent corneal epithelial defect, and age-related macular degeneration, with the goal of improving symptom control, healing, and overall eye health.
- Testing new approaches for dry eye disease and meibomian gland dysfunction
- Evaluating treatments for allergic eye conditions such as AKC and VKC
- Studying therapies aimed at supporting corneal repair and vision preservation
- Assessing options for retinal diseases including AMD and polypoidal choroidal vasculopathy
These studies are designed to measure how well new or existing therapies work, while also monitoring safety and patient comfort in everyday eye care.
Viral and Respiratory Infections
The site also conducts trials in viral diseases and respiratory tract diseases, including research on respiratory syncytial virus and influenza immunisation. This work is centered on strengthening immune protection in older adults and understanding how well vaccines help prevent serious respiratory illness.
- Evaluating immune responses to RSV vaccination in older adults
- Assessing the safety and effectiveness of influenza vaccines
- Supporting prevention strategies for seasonal respiratory infections
These trials aim to improve protection against common but potentially serious infections, especially in populations at higher risk.
Bacterial Infections and Vaccines
Research in bacterial infections at this patient organisation includes studies on pneumococcal disease and vaccine response. The main purpose is to evaluate whether newer vaccines can provide strong immune protection while remaining safe and well tolerated.
- Studying immune responses to pneumococcal vaccination
- Comparing vaccine performance in older adults
- Measuring protection against serious bacterial infection
By focusing on prevention, these trials help clarify how vaccination can reduce the burden of infections in the community.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 55 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 53 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Dompe' Farmaceutici S.p.A.2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Dompe' Farmaceutici S.p.A.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Fundacion De Oftalmologia Medica De La Comunitat Valenciana
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Study to Demonstrate Efficacy and Safety of DFL24498 Eye Drop Solution in Adult Participants with Atopic Keratoconjunctivitis (AKC) | Dompe' Farmaceutici S.p.A. | Phase III | Recruiting | Nov 2025 | — |
IMP list
lock Showing 1 of 55 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S,34R)-30-Ethyl-34-[(E,2R)-Hex-4-En-2-Yl]-4,7,10,12,15,19,25,28-Octamethyl-33-(Methylamino)-6,9,18,24-Tetrakis(2-Methylpropyl)-3,21-Di(Propan-2-Yl)-1-Oxa-4,7,10,13,16,19,22,25,28,31-Decazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-Undecone Hydrochloride | 1 | Unknown | 2025-11-27 | 2025-11-27 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.